Imaging in Neovascular Age-Related Macular Degeneration
暂无分享,去创建一个
[1] Joan W. Miller,et al. Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. , 2010, American journal of ophthalmology.
[2] K Bailey Freund,et al. Outer retinal tubulation: a novel optical coherence tomography finding. , 2009, Archives of ophthalmology.
[3] Amitha Domalpally,et al. QUALITY ISSUES IN INTERPRETATION OF OPTICAL COHERENCE TOMOGRAMS IN MACULAR DISEASES , 2009, Retina.
[4] S. Schwartz,et al. Age-related macular degeneration: experimental and emerging treatments , 2009, Clinical ophthalmology.
[5] A. Bird,et al. FUNDUS AUTOFLUORESCENCE IMAGING: Review and Perspectives , 2008, Retina.
[6] C. Regillo,et al. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. , 2007, American journal of ophthalmology.
[7] Anat Loewenstein,et al. Retinal pigment epithelial detachment. , 2007, Survey of ophthalmology.
[8] M. Mandai,et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. , 2006, American journal of ophthalmology.
[9] N. Bressler,et al. Chapter 61 – Neovascular (Exudative) Age-Related Macular Degeneration , 2005 .
[10] Richard F Spaide,et al. COMPARISON OF FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY FOR PATIENTS WITH CHOROIDAL NEOVASCULARIZATION AFTER PHOTODYNAMIC THERAPY , 2005, Retina.
[11] W. Brannath,et al. Optical coherence tomography guided retreatment of photodynamic therapy , 2005, British Journal of Ophthalmology.
[12] S. J. Talks,et al. Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes , 2005, British Journal of Ophthalmology.
[13] F. Roudot-thoraval,et al. Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration , 2004, British Journal of Ophthalmology.
[14] Michael D. Ober,et al. Ophthalmic fundus imaging: today and beyond. , 2004, American journal of ophthalmology.
[15] S. C. Lee,et al. Choroidal neovascularization characteristics and its size in optical coherence tomography. , 2003, Yonsei medical journal.
[16] J. Jonas. VERTEPORFIN THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: Meta-Analysis of 2-Year Safety Results in Three Randomized Clinical Trials: Treatment of Age-Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Study Report , 2002, American journal of ophthalmology.
[17] J. Slakter,et al. RETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION , 2001, Retina.
[18] C Bellman,et al. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. , 2001, Investigative ophthalmology & visual science.
[19] T. Stokkermans,et al. Treatment of age-related macular degeneration. , 2000, Clinical eye and vision care.
[20] J. Ceuppens,et al. HYPOTENSIVE SHOCK AS A COMPLICATION OF INFRACYANINE GREEN INJECTION , 1998, Retina.
[21] Flower Rw,et al. Disparity between fundus camera and scanning laser ophthalmoscope indocyanine green imaging of retinal pigment epithelium detachments. , 1998 .
[22] C S Yang,et al. Digital indocyanine green angiography in chorioretinal diseases. , 1995, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.
[23] E. Gaillard,et al. PHOTOPHYSICAL STUDIES ON HUMAN RETINAL LIPOFUSCIN , 1995, Photochemistry and photobiology.
[24] R P Murphy,et al. Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. , 1991, Ophthalmology.
[25] J. Weiter,et al. Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. , 1989, Investigative ophthalmology & visual science.
[26] Steffen Schmitz-Valckenberg,et al. Fundus autofluorescence and progression of age-related macular degeneration. , 2009, Survey of ophthalmology.
[27] Andrea Hassenstein,et al. Clinical use and research applications of Heidelberg retinal angiography and spectral‐domain optical coherence tomography – a review , 2009, Clinical & experimental ophthalmology.
[28] William J Feuer,et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.
[29] M. M. Ballús,et al. Indocyanine green angiography in chorioretinal diseases: indications and interpretation , 2003 .
[30] Jennifer I. Lim,et al. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. , 2003, Ophthalmology.
[31] Neil M Bressler,et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.
[32] N. Bressler,et al. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.
[33] J. Lim,et al. Anaphylactic shock following indocyanine green angiography. , 1996, Archives of ophthalmology.
[34] E S Gragoudas,et al. Adverse reactions due to indocyanine green. , 1994, Ophthalmology.
[35] L A Yannuzzi,et al. IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV) , 1990, Retina.
[36] J. Weiter,et al. CELL LOSS IN THE AGING RETINA , 1989 .